This document provides an overview and table of contents for a report on 3D printing for healthcare from 2014-2024. The report will cover the market size and forecasts for 3D printing technology and products in healthcare by application. It will also analyze the leading national markets and profile major organizations. Chapter outlines include introductions to 3D printing and bioprinting, market analysis by technology/product and application, leading country markets, key organizations, the R&D pipeline, and qualitative industry analysis.
2. Contents
1. Executive Summary
1.1 What This Report Covers
1.2 Overview of 3D Printing for Healthcare: Industry and Market 2014-2024
1.3 Chapter Outlines
1.4 Research and Analysis Methods
2.
An Introduction to 3D Printing for the Healthcare Industry
2.1 3D Printing
2.1.1 The Original 3D Printing Process
2.1.2 Selective Laser Sintering (SLS)
2.1.3 Direct Metal Laser Sintering (DMLS)
2.1.4 Electron Beam Melting (EBM)
2.1.5 Stereolithography (SLA)
2.2 Bioprinting: The Printing of Living Cells
2.2.1 How 3D Printing With Living Tissue Works
2.2.2 The Near- and Long-Term Applications for 3D Bioprinting
2.2.3 Current Problems With 3D Bioprinting
2.3 The 3D Printing of Pharmaceuticals
2.3.1 3D Printing Technology in Drug Discovery
2.4 Classifying Medical Devices
2.4.1 The US Medical Devices Classification System
2.4.2 The EU Medical Devices Classification System
3. The 3D Printing Market for the Healthcare Industry, 2014-2024
3.1 The 3D Printing Market for Healthcare in 2012: Technology vs. Products
www.visiongain.com
3. Contents
3.2 3D Printed Products in the Healthcare Industry: A Breakdown by Application
3.3 The 3D Printing Market for Healthcare: An Overarching Revenue Forecast 2014-2024
3.4 The Driving and Restraining Factors of the Industry
3.5 3D Printing Technology for Healthcare: Revenue Forecast 2014-2024
3.6 3D Printed Products for Healthcare by Application: Revenue Forecast 2014-2024
3.6.1 Dental Products Dominated the 3D Printed Products Market in 2012, But Will This
Continue?
3.6.2 Medical Implants: Patient-Specific Orthopaedic and Cranio-maxillofacial Implants Are
Produced Using 3D Printing Technology
3.6.2.1 The Driving and Restraining Factors Surrounding 3D Printed Medical Implants,
2013
3.6.3 Bioprinted Tissue: Commercial Launch Anticipated in 2014
3.6.4 Other Applications: Medical Modelling, Prototypes and Pharmaceuticals
4.
The Leading National Markets for 3D Printing for Healthcare,
2014-2024
4.1 A Geographical Breakdown of 3D Printing Technology Manufacturers for the Healthcare
Industry, 2012
4.2 The Leading National Markets for 3D Printing in Healthcare, 2012
4.3 The Leading National Markets: Comparison of Revenue and Market Share, 2018 and 2024
4.4 The Leading National Pharmaceutical Markets for 3D Printing for Healthcare: A Grouped
Revenue Forecast, 2014-2024
4.5 The US Will Continue to be the Largest Consumer Throughout the Forecast Period
4.5.1 Pioneering Use of 3D Printed Medical Implants in the US
4.5.2 FDA Regulatory Requirements: Abridged Pathways Foster Innovation
www.visiongain.com
4. Contents
4.6 The EU5 Account for 30% of the Market in 2012, But How Will This Change During the
Forecast Period 2014-2024?
4.6.1 Germany Will Remain the Largest Market of the EU5 Throughout the Forecast Period
4.6.2 France: Strong Growth but a Decreasing Market Share
4.6.3 The UK: A Strong Network for 3D Printed Medical Implants Will Stimulate Sales of
those Products
4.6.4 Italian Orthopaedic Device Manufacturers are Prominent Consumers of Arcam’s AM
Technology
4.6.5 Spain: the Smallest of the EU5 Will See the Highest Growth
4.7 Japan: Growth Will be Driven by Domestic as well as International Innovation
4.8 China: Domestic Innovation is Keeping Pace With the Western World
4.9 Brazil: A Rapidly Growing Dental Market Presents Opportunities for 3D Printing
4.10 The Indian Market is at an Early Stage
4.11 Will 3D Printing Penetrate the Russian Healthcare Market?
5.
3D Printing for Healthcare: Leading Organisations in the Market
5.1 Leading Organisations in the Industry, 2013-2014
5.2 Organisations in the Medical Implants Sector
5.2.1 Tissue Regeneration Systems: Commercialising 3D Printed Bioresorbable Skeletal
Reconstruction Implants
5.2.2 Oxford Performance Materials: Selling 3D Printed Implants Since Late 2011
5.2.3 Within Technologies: A Manufacturer of Software for 3D Printing
5.2.3.1 Within Medical: A New Initiative Combining Medical Implant Design Software
and a 3D Printing Manufacturing Program
5.2.3.2 The Future of Within Technologies in the Medical Field
www.visiongain.com
5. Contents
5.2.4 C&A Tool: Manufacturing Parts for the Surgical, Orthopaedic, Implant and Tooling
Fields
5.2.5 Tonrud Engineering: A Provider of DMSL Since November 2011
5.2.6 Alphaform AG’s Two Business Segments Will Grow Synergistically
5.2.7 3T RPD Ltd: A UK-Based Additive Manufacturing Company
5.2.8 EOS: A Manufacturer of 3D Printers
5.2.9 Arcam AB is Seeing Rapid Growth in 2013
5.2.10 Xilloc Medical: Specialising in Patient-Specific Implants
5.2.11 LayerWise: A Specialist in Metal Additive Manufacturing
5.2.12 3D Systems: High Rates of Growth in the Healthcare Industry
5.2.13 Stratasys: Merged With Objet in December 2012
5.3 Organisations in the 3D Bioprinting Sector
5.3.1 Wake Forest Institute for Regenerative Medicine: Working to Engineer >30 Tissues
and Organs Using 3D Printing
5.3.1.1 Timeline for Commercially Available Therapeutic Applications
5.3.1.2 Commercial Applications of the Technology in Drug Development
5.3.2 Organovo: An Early Stage Regenerative Medicine Company
5.4 Organisations in Other Industry Sectors
5.4.1 Aprecia Pharmaceuticals: A Unique Oral Drug Delivery System Produced by 3D
Printing Technology
5.4.2 The Cronin Group, University of Glasgow: Working on the 3D Printing of
Pharmaceuticals
5.4.3 EnvisionTEC Provides Seven 3D Printing Systems for a Variety of Applications in the
Medical and Dental Industries
5.4.4 Materialise NV: 3D Printing Medical Models
www.visiongain.com
6. Contents
6.
3D Printing for the Healthcare Industry: The R&D Pipeline, 20132014
6.1 R&D in the Field of Medical Implants
6.1.1 Improving Biocompatibility of 3D Printed Medical Implants with Vitamin B2
6.1.2 3D Printing Intervertebral Discs Could Look Forward to a Share of a $90bn Market
6.1.3 3D Printing of Bionic Organs With Enhanced Functionality
6.2 R&D in the Field of Bioengineering
6.2.1 3D Printing of Skin Grafts: In Hospitals Within 10 Years?
6.2.2 The Production of Implantable Cartilage Using 3D Printing
6.2.3 3D Printing Blood Vessels is a Step Towards the Fabrication of Organs
6.2.3.1 Work at the University of Pennsylvania and MIT
6.2.3.2 Work at Fraunhofer
6.2.4 3D Printing of Functioning Livers at Organovo
6.2.5 3D Printing of Replacement Ears for Reconstructive Surgery
6.2.6 3D Printing to Fabricate Artificial Heart Valves
6.2.7 3D Printing Miniature Spheres With a Lipid Bilayer: Mimicking the Membranes of
Living Cells
6.3 R&D in Other Fields
6.3.1 The 3D Printing of Pharmaceuticals: The Potential to Improve Access to
Pharmaceuticals in Remote Corners of the World?
7.
Qualitative Analysis of the 3D Printing Industry for Healthcare,
2013-2014 Onwards
7.1 Strengths and Weaknesses of the 3D Printing Industry for Healthcare at the End of 2013
7.1.1 The Market is in a High Growth Phase
www.visiongain.com
7. Contents
7.1.2 AM Has a Smaller Resource Footprint
7.1.3 Customised Implants are in High Demand
7.1.4 Producing Complex Shapes and Parts
7.1.5 With High Volume, the Technology is Inefficient
7.1.6 3D Printing Remains Expensive
7.1.7 The Impact of the Adoption of 3D Printing on Jobs in Medical Manufacturing
Industries
7.2 Opportunities and Threats Facing the Industry and Market, 2014-2024
7.2.1 Uses of 3D Printing in the Healthcare Industry Expand
7.2.2 The Demand for Personalised Medicine Represents a Lucrative Opportunity
7.2.3 There Exists Much Governmental Investment in the Technologies
7.2.4 Opportunities in Post-Production Finishing
7.2.5 Threats Posed by Questions Over Legal Responsibility and Rights
7.2.6 Threats Posed by Alternative Manufacturing Methods
7.3 The Social, Technological, Economic and Political Factors Influencing the 3D Printing
Industry for Healthcare, 2014-2024
7.3.1 Social Influences on Market Trends
7.3.2 Technological Influences on Market Trends
7.3.3 Economic Influences on the Market
7.3.4 Political Influences on the Market
8.
Research Interviews
8.1 Interview with Andy Middleton, General Manager, EMEA (Europe, Middle East and Africa),
Stratasys
8.1.1 On Stratasys’ Offerings for the Healthcare Industry
www.visiongain.com
8. Contents
8.1.2 On the Demand for 3D Printing in Healthcare
8.1.3 On the Future of 3D Printing in the Healthcare Industry
8.2 Interview with Dr Lothar Koch, Head of Biofabrication Group in the Nanotechnology
Department, Laser Zentrum Hannover
8.2.1 On Laser-Assisted BioPrinting
8.2.2 On the Uses of 3D Printed Tissue
8.2.3 On 3D Printed Tissue vs. Traditional In Vitro Models
8.2.4 On 3D Printed Tissue for Transplantation
8.2.5 On Research in the Field
8.2.6 On the Timeline for Commercial Availability
8.3 Interview with Michael Renard, Executive Vice President, Commercial Operations, Organovo
8.3.1 On the Applications for 3D Bioprinting
8.3.2 On the Commercial Prospects of the Technology
8.3.3 On Potential Factors That Could Inhibit Development
8.3.4 On the Timeline for the Use of Bioprinted Tissues in Therapy
9.
Conclusions from Our Study
9.1 The 3D Printing Market for the Healthcare Industry: Technology vs. End Products, 2014-2024
9.2 3D Printed Products for the Healthcare Industry by Application: Comparison of Revenue,
2012, 2018 and 2024
9.3 The Leading National Markets for 3D Printing in the Healthcare Industry, 2014-2024
9.4 Trends in the Industry and Market
9.4.1 3D Printing Technology is Already Established in the Field of Dentistry
9.4.2 The Uptake of 3D Printed Orthopaedic Implants is Gathering Pace
9.4.3 An Increasing Focus on Bioprinting
www.visiongain.com
10. Contents
List of Tables
Table 1.1 Currency Exchange Rates
Table 2.1 The US Classification of Medical Devices
Table 2.2 The EU Classification of Medical Devices
Table 3.1 Breakdown of the Market by Technology and Products: Revenue ($m) and Market
Share (%), 2012
Table 3.2 3D Printed Products for Healthcare by Application: Revenues ($m) and Market Shares
(%), 2012
Table 3.3 3D Printing in the Healthcare Industry by Submarket: Revenue ($m) and Market Share
(%) Forecasts, 2013-2024
Table 3.4 3D Printing Technology for Healthcare: Revenue Forecast ($m), 2013-2024
Table 3.5 3D Printed Products for Healthcare by Application: Revenue ($m) and Market Share
(%) Forecasts, 2013-2024
Table 3.6 3D Printed Dental Products: Revenue ($m) and Market Share (%) Forecast, 2013-2024
Table 3.7 3D Printed Medical Implants: Revenue ($m) and Market Share (%) Forecast, 20132024
Table 3.8 Bioprinted Tissue: Revenue ($m) and Market Share (%) Forecast, 2013-2024
Table 3.9 Other Applications: Revenue ($m) and Market Share (%) Forecast, 2013-2024
Table 4.1 Geographical Breakdown of 3D Printing Technology Manufacturers for Healthcare:
Revenue ($m) and Market Share (%) by Region, 2012
Table 4.2 Leading National Markets for 3D Printing Technology and 3D Printed Products for
Healthcare: Revenue ($m) and Market Share (%), 2012
Table 4.3 The Leading National Markets for Sales of 3D Printing Technology and 3D Printed
Products for Healthcare: Comparisons of Revenue ($m) and Market Share (%), 2018 and 2024
Table 4.4 The Leading National Markets for Sales of 3D Printing Technology and 3D Printed
Products for Healthcare: Revenue Forecasts ($m), 2013-2024
www.visiongain.com
11. Contents
Table 4.5 The US 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%)
Forecast, 2013-2024
Table 4.6 The EU5: National Revenue ($m) and Market Share (%) Forecasts, 2013-2024
Table 4.7 The German 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%)
Forecast, 2013-2024
Table 4.8 The French 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%)
Forecast, 2013-2024
Table 4.9 The UK 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%)
Forecast, 2013-2024
Table 4.10 The Italian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%)
Forecast, 2013-2024
Table 4.11 The Spanish 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%)
Forecast, 2013-2024
Table 4.12 The Japanese 3D Printing Market for Healthcare: Revenue ($m) and Market Share
(%) Forecast, 2013-2024
Table 4.13 The Chinese 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%)
Forecast, 2013-2024
Table 4.14 The Brazilian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%)
Forecast, 2013-2024
Table 4.15 The Indian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%)
Forecast, 2013-2024
Table 4.16 The Russian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%)
Forecast, 2013-2024
Table 5.1 Prominent Organisations in the 3D Printing Market for the Healthcare Industry, End of
2013
Table 5.2 Prominent Organisations in the Medical Implant Market, End of 2013
www.visiongain.com
12. Contents
Table 5.3 Medical Implants Designed by Within Technologies' Software, 2013
Table 5.4 Alphaform: Breakdown of Revenue ($m, %) by Business Segment, 2012
Table 5.5 Arcam: Breakdown of System Sales to the Medical Implant Industry by Country, 19972012
Table 5.6 Materials Used by Xilloc Medical, 2013
Table 5.7 The Main Organisations 3D Bioprinting Market, 2013
Table 5.8 Prominent Organisations in Other Industry Sectors Using 3D Printing, 2013
Table 5.9 EnvisionTEC 3D Printing Systems for the Medical and Dental Industries, 2013
Table 6.1 Improving Biocompatibility of 3D Printed Medical Implants: Main Facts, 2013
Table 6.2 3D Printing Intervertebral Discs: Main Facts, 2013
Table 6.3 3D Printing of Bionic Organs: Main Facts, 2013
Table 6.4 3D Printing of Skin Grafts: Main Facts, 2013
Table 6.5 3D Printed Cartilage: Main Facts, 2013
Table 6.6 3D Printing of Blood Vessels: Main Facts, 2013
Table 6.7 3D Printing of Functioning Liver Tissue: Main Facts, 2013
Table 6.8 3D Printing of Replacement Human Ears: Main Facts, 2013
Table 6.9 3D Printing of Heart Valves: Main Facts, 2013
Table 6.10 3D Printing of Material That Mimics Living Cells: Main Facts, 2013
Table 6.11 3D Printing of Pharmaceuticals: Main Facts, 2013
Table 7.1 Strengths and Weaknesses of the 3D Printing Industry for Healthcare, 2013-2014
Table 7.2 Opportunities and Threats Facing the Industry and Market, 2014-2024
Table 7.3 STEP Analysis: Social, Technological, Economic and Political Forces Influencing the 3D
Printing Market for Healthcare, 2014-2024
www.visiongain.com
13. Contents
List of Figures
Figure 3.1 Breakdown of the Market by Technology and Products: Market Share (%), 2012
Figure 3.2 3D Printed Products for Healthcare by Application: Market Share (%), 2012
Figure 3.3 3D Printing in the Healthcare Industry: An Overarching Revenue Forecast ($m), 20132024
Figure 3.4 The 3D Printing Market for Healthcare by Submarket: Market Share (%), 2018
Figure 3.5 The 3D Printing Market for Healthcare by Submarket: Market Share (%), 2024
Figure 3.6 Driving and Restraining Factors of 3D Printing for Healthcare, 2014
Figure 3.7 3D Printing Technology for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 3.8 Driving and Restraining Factors of 3D Printing Technology in the Healthcare Industry,
2014
Figure 3.9 3D Printed Products for Healthcare by Application: Revenue Forecast ($m), 20132024
Figure 3.10 3D Printed Products by Application: Market Share (%), 2018
Figure 3.11 3D Printed Products by Application: Market Share (%), 2024
Figure 3.12 3D Printed Dental Products: Revenue Forecast ($m), 2013-2024
Figure 3.13 Driving and Restraining Factors of the 3D Printed Dental Product Market, 2014
Figure 3.14 3D Printed Medical Implants: Revenue Forecast ($m), 2013-2024
Figure 3.15 Driving and Restraining Factors of the 3D Printed Medical Implants Market, 2014
Figure 3.16 Bioprinted Tissue: Revenue Forecast ($m), 2013-2024
Figure 3.17 Driving and Restraining Factors of the 3D Bioprinting Market, 2014
Figure 3.18 Other Applications: Revenue Forecast ($m), 2013-2024
Figure 3.19 Driving and Restraining Factors of the Market for Other Applications, 2014
Figure 4.1 Geographical Breakdown of 3D Printing Technology Manufacturers for Healthcare:
Market Share by Region (%), 2012
www.visiongain.com
14. Contents
Figure 4.2 Leading National Markets for Sales of 3D Printing Technology and 3D Printed
Products for Healthcare: Market Share (%), 2012
Figure 4.3 The Leading National Markets for Sales of 3D Printing Technology and 3D Printed
Products for Healthcare: Market Share (%), 2018
Figure 4.4 Leading National Markets for Sales of 3D Printing Technology and 3D Printed
Products for Healthcare: Market Share (%), 2024
Figure 4.5 Leading National Markets for Sales of 3D Printing Technology and 3D Printed
Products for Healthcare: Grouped Revenue Forecast ($m), 2013-2024
Figure 4.6 The US 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.7 The EU5 3D Printing Market for Healthcare: Market Share by Country (%), 2012
Figure 4.8 The EU5: National Revenue Forecasts ($m), 2013-2024
Figure 4.9 The German 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.10 The French 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.11 The UK 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.12 The Italian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.13 The Spanish 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.14 The Japanese 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.15 The Chinese 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.16 The Brazilian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.17 The Indian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.18 The Russian 3D Printing Market For Healthcare: Revenue Forecast ($m), 2013-2024
Figure 5.1 Alphaform: Geographical Distribution of Revenue, 1H2013
Figure 5.2 Alphaform: Breakdown of Revenue by Business Segment (%), 2012
Figure 5.3 Arcam: Breakdown of System Sales by Industry, 1997-2012
www.visiongain.com
15. Contents
Figure 5.4 Arcam: Breakdown of System Sales to the Medical Implant Industry by Country,
1997-2012
Figure 5.5 3D Systems: Breakdown of Revenue by Industry, 3Q 2013
Figure 6.1 3D Printing Technology for Healthcare: Outline of the R&D Pipeline, 2013
Figure 8.1 Orthodontic Model Produced on a Stratasys Objet30 OrthoDesk 3D Printer
Figure 8.2 VeinViewer® Flex designed Using Stratasys 3D Printed Prototypes
Figure 8.3 VeinViewer® Displaying Blood Beneath the Surface of an Adult Female Hand
Figure 8.4 Jorge Vicente Lopes da Silva, Chief of Tridimensional Technologies Division (DT3D CTI), Shows 12-year-old Boy’s Skull Model Produced on an Objet350 Connex Multi-material 3D
Printer
Figure 9.1 3D Printing for the Healthcare Industry: Revenue Forecast ($m) Broken Into
Technology and Products, 2013-2024
Figure 9.2 3D Printed Products for the Healthcare Industry by Application: Comparisons of
Revenue ($m), 2012, 2018 and 2024
Figure 9.3 The Leading National Markets in the 3D Printing Industry for Healthcare: Comparison
of Revenue ($m), 2012, 2018 and 2024
www.visiongain.com
16. Contents
Companies and Organisations Mentioned in the Report
3D Systems Corp
3T RPD
5N Plus
Adler Ortho
Alphaform AG
Aprecia Pharmaceuticals
Arcam AB
Asian Manufacturing Association (AMA)
BestinClass SA
Biomet
C&A Tool
Chinese FDA (CFDA)
Clemson University
Compass3D
Conformité Européenne (CE)
Cornell University
Deloitte
DePuy Synthes
Deutsches Herzzentrum Berlin (DHZB)
DiSanto Technology
EnvisionTEC
EOS
Ernst & Young
www.visiongain.com
17. Contents
Expert 3D Solutions
FirstSurface Ltd.
Food and Drug Administration (US FDA)
Fraunhofer Institutes
Hangzhou Dianzi University
Harvard University
Imaginarium
Industry Alliance of China 3D Printing Technology
Invetech
Johns Hopkins University
Knight Cancer Institute
Kyoto University
Laser Zentrum Hannover
LayerWise
Lexmark
Lima Corporate
Maastricht Instruments B.V.
Massachusetts Institute of Technology (MIT)
Materialise NV
Mattel Children’s Hospital
MCP HEK Tooling
Medical Modelling
Medimet GMBH
Medtronic
Michael J Fox Foundation
www.visiongain.com
18. Contents
Ministry of Industry and Information Technology
Nakashima Medical
National Additive Manufacturing Innovation Institute (NAMII)
North Carolina State University
Nottingham University Hospitals Trust
Objet
OBL
Office of Science and Engineering Laboratories
Oregon Health and Science University
Organovo
Oxford Performance Materials (OPM)
Peking University 3rd Hospital
Pfizer
Princeton University
Protosys Technologies
Queen’s Medical Centre (QMC)
Roche
Royal Perth Hospital, Australia
SIU System
SkinPrint
Smith & Nephew
Sony DADC
State Food and Drug Administration (SFDA)
Stratasys
Stryker
www.visiongain.com
19. Contents
The Cronin Group
The Michael J Fox Foundation
Tissue Regeneration Systems
Tonrud
TU Berlin
UCLA
United Therapeutics
University of Glasgow
University of Michigan
University of North Carolina
University of Oxford
University of Pennsylvania
University of Wisconsin
Wake Forest Institute for Regenerative Medicine (WFIRM)
Walter Reed National Military Medical Center
Weill Cornell Medical College
Within Technologies
Wyss Institute for Biologically Inspired Engineering
Xilloc Medical
Zimmer
www.visiongain.com
20. 3D Printing for Healthcare - R&D,
Industry and Market 2014-2024
market for healthcare will expand at a CAGR of 14.89%. In 2024, sales of 3D printing technology
and 3D printed products for healthcare in Brazil will generate $169m, accounting for 1.98% of the
global market.
4.10 The Indian Market is at an Early Stage
In 2012, sales of 3D printing technology and 3D printed products for healthcare in India generated
revenue of $14m, accounting for 1.3% of the world market. 3D printing is at an early stage in this
region. At present, the most significant application of 3D printing in the Indian healthcare sector is
the production of prototypes and medical models. There are several companies which offer this
service, including Protosys Technologies and Imaginarium.
Mumbai-based Protosys Technologies was established in 1996 and provides stereolithography,
selective laser sintering and fused deposition modelling, as well as basic 3D printing for a range of
industries. However, the field of medicine is an important focus. The company has been providing
medical models for surgeons since 2000, it is reported. These medical models can be produced in
under one week and allow surgeons to more effectively visualise the trauma, plan surgical
procedures, reduce surgery time, and design custom implants for the patient. As healthcare
spending in India increases over the forecast period and knowledge of the benefits of medical
modelling increase, demand for these 3D printed products will increase.
Imaginarium is India’s largest provider of 3D printing, that company reports, providing rapid
prototyping and rapid manufacturing. Imaginarium provides 3D printing solutions to the medical
manufacturing industry and medical professionals in India, including prototyping and low volume
production of medical devices. These include dental, orthopaedic and cranio-maxillofacial implants,
surgical guides, custom prosthetics and anatomical models. Imaginarium has been established for
over 30 years, but the application of the company’s services to the medical industry is relatively
new.
The market is in an early stage at present. However, the demand for 3D printed medical and dental
implants will increase rapidly during the forecast period 2014-2024 as knowledge and affordability
of the technology increases. Healthcare spending in the country is set to increase, with a key focus
th
of the government’s 12 five-year-plan 2012-2017 on a thrust in the medical industry. This will
drive the uptake of new technology, such as 3D printing, we believe. However, this uptake will be
restrained by the high cost of 3D printing technology and the raw materials required.
Between 2012 and 2018, the Indian market for 3D printing for healthcare will expand at a CAGR of
26.1%. This rate of growth will slow towards the end of the forecast period, restrained by the high
www.visiongain.com
Page 85
21. 3D Printing for Healthcare - R&D,
Industry and Market 2014-2024
cost of the technology and the continued prominence of other manufacturing methods in the
medical implants market. The penetration of 3D printed medical implants will slow.
Table 4.15 The Indian 3D Printing Market for Healthcare: Revenue ($m) and Market
Share (%) Forecast, 2013-2024
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Market Share (%) 1.30 1.32 1.34 1.36 1.38 1.40 1.44 1.48 1.52 1.56 1.60 1.64 1.68
Revenue ($m)
14
17
19
23
30
42
58
81
96
110 120 131 144
AGR (%)
15
16
18
32
39
39
40
18
15
9
9
9
CAGR (%)
26.10
16.24
Source: visiongain 2014; CAGR values for year ranges 2012-2018 and 2018-2024
Figure 4.17 The Indian 3D Printing Market for Healthcare: Revenue Forecast ($m),
2013-2024
160
140
Revenue ($m)
120
100
80
60
40
20
0
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Year
Source: visiongain 2014
Between 2018 and 2024, the Indian market for 3D printing for healthcare will expand at a CAGR of
16.24%. In 2024, sales of 3D printing technology and 3D printed products for healthcare in India
will generate $144m, accounting for 1.68% of the global market.
4.11 Will 3D Printing Penetrate the Russian Healthcare Market?
In 2012, sales of 3D printing technology and 3D printed products for healthcare in Russia
generated revenue of $18m, accounting for 1.6% of the global market, visiongain estimates. Over
the course of the forecast period 2014-2024, this market will see strong growth as knowledge
regarding the capabilities and advantages of 3D printing spread and healthcare spending
www.visiongain.com
Page 86